Functionally Enhanced siRNA Targeting TNFalpha Attenuates DSS-induced Colitis and TLR-mediated Immunostimulation in Mice doi: 10.1038/mt.2011.236

SM Ocampo; C Romero; A Aviñó; J Burgueño; MA Gassull; J Bermúdez; R Eritja; E Fernandez; JC Perales

Functionally Enhanced siRNA Targeting TNFalpha Attenuates DSS-induced Colitis and TLR-mediated Immunostimulation in Mice doi: 10.1038/mt.2011.236

SM Ocampo, C Romero, A Aviñó, J Burgueño, MA Gassull, J Bermúdez, R Eritja, E Fernandez, JC Perales

Department of Cellular Biology, Physiology and Immunology

Research output: Contribution to journal › Article › Research

Original language	English
Pages (from-to)	382-390
Journal	Molecular Therapy.
Volume	20
Issue number	2
Publication status	Published - 1 Jan 2012

Cite this

@article{47f0b17577f74221b6d2e1e50c147301,

title = "Functionally Enhanced siRNA Targeting TNFalpha Attenuates DSS-induced Colitis and TLR-mediated Immunostimulation in Mice doi: 10.1038/mt.2011.236",

author = "SM Ocampo and C Romero and A Avi{\~n}{\'o} and J Burgue{\~n}o and MA Gassull and J Berm{\'u}dez and R Eritja and E Fernandez and JC Perales",

year = "2012",

month = jan,

day = "1",

language = "English",

volume = "20",

pages = "382--390",

journal = "Molecular Therapy",

issn = "1525-0016",

number = "2",

}

Functionally Enhanced siRNA Targeting TNFalpha Attenuates DSS-induced Colitis and TLR-mediated Immunostimulation in Mice doi: 10.1038/mt.2011.236. / Ocampo, SM; Romero, C; Aviñó, A; Burgueño, J; Gassull, MA; Bermúdez, J; Eritja, R; Fernandez, E; Perales, JC.

In: Molecular Therapy., Vol. 20, No. 2, 01.01.2012, p. 382-390.

Research output: Contribution to journal › Article › Research

TY - JOUR

T1 - Functionally Enhanced siRNA Targeting TNFalpha Attenuates DSS-induced Colitis and TLR-mediated Immunostimulation in Mice doi: 10.1038/mt.2011.236

AU - Ocampo, SM

AU - Romero, C

AU - Aviñó, A

AU - Burgueño, J

AU - Gassull, MA

AU - Bermúdez, J

AU - Eritja, R

AU - Fernandez, E

AU - Perales, JC

PY - 2012/1/1

Y1 - 2012/1/1

M3 - Article

VL - 20

SP - 382

EP - 390

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 2

ER -